Ligand Pharmaceuticals Incorpor | ||||
NGM : LGND || Location: United States | ||||
$73.1+1.83 (+2.57%) |
0.1 M | 71.29 - 73.42 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 0.876 M |
Feb. 29, 2024 | 0.763 M |
Feb. 15, 2024 | 0.897 M |
Jan. 31, 2024 | 0.930 M |
Jan. 12, 2024 | 0.921 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | 0.67 | 1.38 | 104.75% |
09/30/2023 | 0.62 | 1.02 | 63.93% |
06/30/2023 | 0.65 | 1.42 | 117.62% |
03/31/2023 | 0.91 | 2.28 | 150.03% |
12/31/2022 | 1.22 | 1.36 | 11.74% |
Recent Dividends
Div Date | Div Amount |
---|---|
04/03/2007 | 2.50 |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 17.705M | Shares Float | 16.691M |
Short Float | 0.876M | Market Cap | 1261.84M |
Institution ownership | 94.15% | Insider ownership | 5.838% |
Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
Trailing EPS | 3.03 | Forward EPS | 5.60 |